CTLA4 and breast cancer: Demaria et al. in 2005 explored the effects of combined radiotherapy and ICIs on mouse models of breast cancer, particularly in a poorly immunogenic mouse model of breast cancer, where the combination of local radiotherapy and anti-CTLA-4 immune checkpoint inhibition significantly prolonged survival and reduced lung metastasis.